David Allen Stamler
Chief Executive Officer, Director · ALTERITY THERAPEUTICS LTD
- 2026
- Sep 8, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Allen Stamler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Ashley Marks - $48K in ATHE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Allen Stamler?
David Allen Stamler is a corporate insider, tracked as Chief Executive Officer, Director of ALTERITY THERAPEUTICS LTD (ATHE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Allen Stamler submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David Allen Stamler been buying or selling stock?
Recorded transactions: 1 open-market purchase ($24K) and 0 open-market sales across all tracked filings.